Table 2.

Viral loads correlated with plasma IgG and IgA at 6 months in the tenofovir and placebo arms

HIV-Antigen	Viral Load versus Plasma IgG (Tenofovir) n=23		Viral Load versus Plasma IgG (Placebo) n=23		Viral Load versus Plasma IgA (Tenofovir) n=23		Viral Load versus Plasma IgA (Placebo) n=23
	r-value	pvalue	r-value	pvalue	r-value	p-value	r-value	p-value
gp70 V1V2	0.004	NS	0.39	0.06	0.26	NS	0.17	NS
Clade C V3 Linear Epitope	0.02	NS	0.58	0.003*	−0.1	NS	0.59	0.003*
Consensus Group M gp120	0.41	0.05	0.55	0.007*	0.08	NS	0.47	0.03
1086 C.gp140	0.52	0.01	0.44	0.03*	0.07	NS	0.43	0.04
Consensus Group M gp140	0.23	NS	0.43	0.04*	0.06	NS	0.53	0.009*
Consensus Clade C Env gp140	0.35	0.09	0.44	0.03*	0.19	NS	0.53	0.009*
Consensus Clade B gp41 ID epitope	0.48	0.02	0.45	0.03*	−0.08	NS	0.33	NS
Gp41	0.43	0.03	0.49	0.02*	0.07	NS	0.46	0.02
p66	0.02	NS	0.73	<0.0001*	0.41	0.05	0.38	0.07
p24	0.02	NS	0.61	0.002*	−0.03	NS	0.08	NS

P<0.05 indicates statistically significant correlation. NS, not significant.

^*Remains significant after false discovery rate adjustment.